ArticleJournal of managed care & specialty pharmacy2023

Risk of chemotherapy-induced febrile neutropenia in intermediate-risk regimens: Clinical and economic outcomes of granulocyte colony-stimulating factor prophylaxis.

Saad Aslam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.